Clinical Trial Update: FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

The update reports the completion of a Phase 3 trial (FACTS II) evaluating a new medication for active Ulcerative Colitis. The study lists Otsuka Pharmaceutical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Investigational medication (FACTS II)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED